Data / Form D filings / BIOXINESS PHARMACEUTICALS, INC.
BIOXINESS PHARMACEUTICALS, INC.: Form D filings
BIOXINESS PHARMACEUTICALS, INC., a pharmaceuticals company in Hercules, CA, filed 3 Form D notices with the SEC between 2009 and 2016. The latest, on September 21, 2016, reports $502,000 sold of a $1 million offering to 29 investors.
Find out what BIOXINESS PHARMACEUTICALS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 750 ALFRED NOBEL DRIVE SUITE 106, Hercules, CA, 94547
- Phone
- (510) 724-1548
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- California
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1470930
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 21, 2016 | New notice | $1,000,000 | $502,000 | $498,000 | 29 | Sep 6, 2016 | sec.gov |
| Jan 20, 2011 | Amendment | $2,000,000 | $302,568 | $1,697,432 | 8 | Jun 5, 2009 | sec.gov |
| Sep 4, 2009 | New notice | $350,000 | $85,000 | $265,000 | 3 | Jun 5, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Clinton Severson | Director | |
| Matthew Kerby | Director | |
| Constance McKee | Director | |
| Susan Froshauer | Director | |
| Mansour Bassiri | Executive Officer, Director, Promoter |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Sep 19, 2016 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what BIOXINESS PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.